Haemophilus b conjugate (meningococcal protein conjugate) and Hepatitis B (recombinant) vaccine (Merck & Co.)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHaemophilus b conjugate (meningococcal protein conjugate) and Hepatitis B (recombinant) vaccine (Merck & Co.)
Drug Alias NameBๅž‹ๅ—œ่ก€ๆ†่Œ็ผ€ๅˆ็‰ฉ๏ผˆ่„‘่†œ็‚Ž็ƒ่Œ่›‹็™ฝ่ดจ็ผ€ๅˆ็‰ฉ๏ผ‰ๅ’Œไน™ๅž‹่‚็‚Ž๏ผˆ้‡็ป„๏ผ‰็–ซ่‹—๏ผˆ้ป˜ๅ…‹้›†ๅ›ข๏ผ‰Comvax
ClassificationVaccines > Development/production technology > Conjugated vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis BHaemophilus Infections
Global Approved IndicationsHepatitis BHaemophilus Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1996/10/02
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsHepatitis BHaemophilus Infections

Other Information

ATC CodeJ07AG01
Related LinksN/A